Clinical evaluation of the effect of siddha classical drug THIPPILI LEHIYAM and KOTTA KUDINEER for the treatment of CHILDHOOD ASTHMA.

Clinical evaluation of the effect of THIPPILI LEHIYAM and KOTTA KUDINEER for the treatment of BALAR IRAIPPU NOI.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/030908

Enrollment

Registered

2021-02-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J45- Asthma

Interventions

Intervention1: THIPPILI LEHIYAM: Should be administered orally twice a day after food for a period of 40 days dose:6g. Intervention2: KOTTA KUDINEER: Should be administered orally twice a day after f

Eligibility

Inclusion criteria

Inclusion criteria: subjects with any of the following symptoms will be included in the study 1.Dry cough 2.Recurrent attacks of dyspnoea 3.Hoarseness of voice 4.Frequent hemming 5.Tightness of chest 6.Profuse sweating and wheezing 7.History of allergens and sneezing

Exclusion criteria

Exclusion criteria: 1.Children below 3 years and above 12 years 2.Tuberculosis 3.Chronic bronchitis 4.Acute persistent asthma 5.Autoimmune diseases 6.Cardiac diseases

Design outcomes

Primary

Measure	Time frame
Reduction of following symptoms 1.Dry cough 2.Recurrent attacks of dyspnoea 3.Hoarseness of voice 4.Frequent hemming 5.Tightness of chest 6.Profuse sweating and wheezing Timepoint: After 20 days	—

Secondary

Measure	Time frame
Reduction of Eosinophil countTimepoint: After 4 weeks	—

Countries

India

Contacts

Public ContactDr K Shyamala MDs

Government Siddha Medical College and Hospital, Palayamkottai

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026